International Union of Pharmacology. XII. Classification of opioid receptors.
暂无分享,去创建一个
P B Bradley | P. Bradley | M. Hamon | P. Portoghese | T. Reisine | P S Portoghese | M Hamon | B N Dhawan | F Cesselin | R Raghubir | T Reisine | F. Cesselin | R. Raghubir | B. Dhawan | P. Bradley
[1] Heng Xu,et al. OHMEFENTANYL——A NEW AGONIST FOR μ-OPIATE RECEPTOR , 1985 .
[2] D. Grandy,et al. Analysis of selective binding epitopes for the kappa-opioid receptor antagonist nor-binaltorphimine. , 1995, Molecular pharmacology.
[3] S. Childers,et al. Dynorphin-selective inhibition of adenylyl cyclase in guinea pig cerebellum membranes. , 1989, Molecular pharmacology.
[4] Y. Wong,et al. Activation of Type II Adenylyl Cyclase by the Cloned μ‐Opioid Receptor: Coupling to Multiple G Proteins , 1995, Journal of neurochemistry.
[5] P. Stewart,et al. Evidence for delta opioid receptor subtypes in rat spinal cord: studies with intrathecal naltriben, cyclic[D-Pen2, D-Pen5] enkephalin and [D-Ala2, Glu4]deltorphin. , 1993, The Journal of pharmacology and experimental therapeutics.
[6] G. Kreil,et al. cDNAs encoding [D-Ala2]deltorphin precursors from skin of Phyllomedusa bicolor also contain genetic information for three dermorphin-related opioid peptides. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[7] V. Hruby,et al. Identification of mechanisms and sites of actions of mu and delta opioid receptor activation in the canine intestine. , 1994, The Journal of pharmacology and experimental therapeutics.
[8] J. Chen,et al. Ohmefentanyl--a new agonist for mu-opiate receptor. , 1985, Scientia Sinica. Series B, Chemical, biological, agricultural, medical & earth sciences.
[9] J. Meunier,et al. μ‐Opioid Receptors and Not K‐Opioid Receptors Are Coupled to the Adenylate Cyclase in the Cerebellum , 1990 .
[10] G. Pasternak,et al. Mapping of opioid receptors using antisense oligodeoxynucleotides: correlating their molecular biology and pharmacology. , 1995, Trends in pharmacological sciences.
[11] G. Pasternak,et al. Meptazinol: a novel Mu-1 selective opioid analgesic. , 1984, Journal of Pharmacology and Experimental Therapeutics.
[12] B. Roques,et al. δ‐Opioid mediated inhibitions of acute and prolonged noxious‐evoked responses in rat dorsal horn neurones , 1989, British journal of pharmacology.
[13] P. Schiller,et al. Synthesis and binding characteristics of tritiated TIPP[psi], a highly specific and stable delta opioid antagonist. , 1995, Life sciences.
[14] W. Bowen,et al. Differential antagonism of opioid delta antinociception by [D-Ala2,Leu5,Cys6]enkephalin and naltrindole 5'-isothiocyanate: evidence for delta receptor subtypes. , 1991, The Journal of pharmacology and experimental therapeutics.
[15] P. Portoghese,et al. Spinal delta 2-, but not delta 1-, mu-, or kappa-opioid receptors are involved in the tail-flick inhibition induced by beta-endorphin from nucleus raphe obscurus in the pentobarbital-anesthetized rat. , 1995, European Journal of Pharmacology.
[16] H. Emrich,et al. Psychotomimesis mediated by kappa opiate receptors , 1986, Science.
[17] Differential regulation of D1 dopamine receptor- and of A2a adenosine receptor-stimulated adenylyl cyclase by mu-, delta 1-, and delta 2-opioid agonists in rat caudate putamen. , 1995, Journal of neurochemistry.
[18] H. Yamamura,et al. Extremely long-lasting antagonistic actions of nor-binaltorphimine (nor-BNI) in the mouse tail-flick test. , 1992, The Journal of pharmacology and experimental therapeutics.
[19] Shigetada Nakanishi,et al. Cloning and sequence analysis of cDNA for porcine β-neo-endorphin/dynorphin precursor , 1982, Nature.
[20] G. Uhl,et al. -mu opiate receptor. Charged transmembrane domain amino acids are critical for agonist recognition and intrinsic activity. , 1994, The Journal of biological chemistry.
[21] M. Kelly,et al. Opioids act at μ-receptors to hyperpolarize arcuate neurons via an inwardly rectifying potassium conductance , 1990, Brain Research.
[22] L. Buéno,et al. Central μ-, δ- and κ-opioid influences on intestinal water and electrolyte transport in dogs , 1988, Regulatory Peptides.
[23] I. Ferrer,et al. Diarrhea associated with intestinal inflammation increases the potency of mu and delta opioids on the inhibition of gastrointestinal transit in mice. , 1994, The Journal of pharmacology and experimental therapeutics.
[24] M. E. Lewis,et al. Pharmacological and anatomical evidence of selective μ, δ, and χ opioid receptor binding in rat brain , 1986, Brain Research.
[25] G. Bell,et al. Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors. , 1994, Molecular pharmacology.
[26] V. Hruby,et al. SNC 80, a selective, nonpeptidic and systemically active opioid delta agonist. , 1995, The Journal of pharmacology and experimental therapeutics.
[27] A. Goldstein,et al. Expression cloning of cDNA encoding a seven-helix receptor from human placenta with affinity for opioid ligands. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[28] G. Pasternak,et al. Nalbuphine, a mixed kappa 1 and kappa 3 analgesic in mice. , 1992, The Journal of pharmacology and experimental therapeutics.
[29] W. Sadee,et al. A human neuroblastoma cell line expresses mu and delta opioid receptor sites. , 1986, The Journal of biological chemistry.
[30] G. Pasternak,et al. Naloxone benzoylhydrazone (NalBzoH) analgesia. , 1990, The Journal of pharmacology and experimental therapeutics.
[31] E. Barnard,et al. Guanine nucleotide-binding protein-coupled and -uncoupled states of opioid receptors and their relevance to the determination of subtypes. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[32] R. Lahti,et al. U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist. , 1983, The Journal of pharmacology and experimental therapeutics.
[33] A. Lipkowski,et al. Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action. , 1989, The Journal of pharmacology and experimental therapeutics.
[34] M. Adler,et al. Effect of ambient temperature on the ability of mu-, kappa- and delta-selective opioid agonists to modulate thermoregulatory mechanisms in the rat. , 1994, The Journal of pharmacology and experimental therapeutics.
[35] P. Seeburg,et al. Molecular characterization of a new immunoglobulin superfamily protein with potential roles in opioid binding and cell contact. , 1989, The EMBO journal.
[36] S. Kaneko,et al. Cloning and expression of a cDNA for the rat kappa-opioid receptor. , 1993, FEBS letters.
[37] C. Chavkin,et al. Dynorphin is a specific endogenous ligand of the kappa opioid receptor. , 1982, Science.
[38] J. K. Chang,et al. Potent morphiceptin analogs: structure activity relationships and morphine-like activities. , 1983, The Journal of pharmacology and experimental therapeutics.
[39] G. Uhl,et al. Human kappa opiate receptor second extracellular loop elevates dynorphin's affinity for human mu/kappa chimeras. , 1994, The Journal of biological chemistry.
[40] H. Akil,et al. Primary structure and functional expression of a guinea pig kappa opioid (dynorphin) receptor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[41] R. Lewis,et al. Analgesic and mechanistic evaluation of spiradoline, a potent kappa opioid. , 1988, The Journal of pharmacology and experimental therapeutics.
[42] P. Schiller,et al. Differential stereochemical requirements of mu vs. delta opioid receptors for ligand binding and signal transduction: development of a class of potent and highly delta-selective peptide antagonists. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[43] A. Lipkowski,et al. Bimorphinans as highly selective, potent kappa opioid receptor antagonists. , 1987, Journal of medicinal chemistry.
[44] Y. Itzhak. Multiple Opioid Binding Sites , 1988 .
[45] V. Hruby,et al. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse. , 1984, The Journal of pharmacology and experimental therapeutics.
[46] R. Lahti,et al. Properties of a selective kappa agonist, U-50,488H. , 1982, Life sciences.
[47] S. Rane,et al. Nucleotide-independent modulation of Ca(2+)-dependent K+ channel current by a mu-type opioid receptor. , 1994, Molecular pharmacology.
[48] T. Nakagawa,et al. DAMGO, a mu-opioid receptor selective agonist, distinguishes between mu- and delta-opioid receptors around their first extracellular loops. , 1995, FEBS letters.
[49] K. Mori,et al. Primary structures and expression from cDNAs of rat opioid receptor delta- and mu-subtypes. , 1993, FEBS letters.
[50] H. Kosterlitz,et al. CHARACTERIZATION OF THE k‐SUBTYPE OF THE OPIATE RECEPTOR IN THE GUINEA‐PIG BRAIN , 1981 .
[51] I. Zagon,et al. Zeta (ξ), a growth-related opioid receptor in developing rat cerebellum: identification and characterization , 1991, Brain Research.
[52] S. Salvadori,et al. Frog skin opioid peptides: a case for environmental mimicry. , 1994, Environmental health perspectives.
[53] R. Zukin,et al. Neuroanatomical patterns of the mu, delta, and kappa opioid receptors of rat brain as determined by quantitative in vitro autoradiography. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[54] M. Brownstein. A brief history of opiates, opioid peptides, and opioid receptors. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[55] H. Loh,et al. Identification of three separate guanine nucleotide-binding proteins that interact with the delta-opioid receptor in NG108-15 neuroblastoma x glioma hybrid cells. , 1992, Molecular pharmacology.
[56] G. Pasternak,et al. Antisense mapping the MOR‐1 opioid receptor: evidence for alternative splicing and a novel morphine‐6β‐glucuronide receptor , 1995, FEBS letters.
[57] T. Petcher,et al. Bremazocine: a potent, long-acting opiate kappa-agonist. , 1980, Life sciences.
[58] S. Snyder,et al. Opiate Receptor: Demonstration in Nervous Tissue , 1973, Science.
[59] M. Dichter,et al. The cloned kappa opioid receptor couples to an N-type calcium current in undifferentiated PC-12 cells , 1994, Neuroscience.
[60] T. Cicero,et al. Affinity of drugs and peptides for U-69,593-sensitive and -insensitive kappa opiate binding sites: the U-69,593-insensitive site appears to be the beta endorphin-specific epsilon receptor. , 1990, The Journal of pharmacology and experimental therapeutics.
[61] A. Gintzler,et al. Bimodal Opioid Regulation of Cyclic AMP Formation: Implications for Positive and Negative Coupling of Opiate Receptors to Adenylyl Cyclase , 1994, Journal of neurochemistry.
[62] H. Morris,et al. Identification of two related pentapeptides from the brain with potent opiate agonist activity , 1975, Nature.
[63] G. Bell,et al. Molecular biology of opioid receptors , 1993, Trends in Neurosciences.
[64] H. Yamamura,et al. Binding of BW 373U86, a non-peptidic delta opioid receptor agonist, is not regulated by guanine nucleotides and sodium. , 1993, European journal of pharmacology.
[65] D. L. Larson,et al. A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activities. , 1980, Journal of medicinal chemistry.
[66] P. Portoghese,et al. Agonist and antagonist activities of ligands derived from naltrexone and oxymorphone. , 1992, Life sciences.
[67] M. Yeadon,et al. Multiple opioid receptors mediate the respiratory depressant effects of fentanyl-like drugs in the rat. , 1990, General pharmacology.
[68] P. Schiller,et al. TIPP[psi]: a highly potent and stable pseudopeptide delta opioid receptor antagonist with extraordinary delta selectivity. , 1993, Journal of medicinal chemistry.
[69] A. Faden,et al. Kappa opioid receptors modulate cardiorespiratory function in hindbrain nuclei of rat , 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[70] F. Dudek,et al. Direct effects of an opioid peptide selective for μ-receptors: Intracellular recordings in the paraventricular and supraoptic nuclei of the guinea-pig , 1990, Neuroscience.
[71] G. Pasternak,et al. Multiple mu opiate receptors. , 1986, Life sciences.
[72] S. Childers,et al. Opioid‐Inhibited Adenylyl Cyclase in Rat Brain Membranes: Lack of Correlation with High‐Affinity Opioid Receptor Binding Sites , 1992, Journal of neurochemistry.
[73] L. Hood,et al. Porcine pituitary dynorphin: complete amino acid sequence of the biologically active heptadecapeptide. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[74] G. Milligan,et al. Immunoprecipitation of opioid receptor-Go-protein complexes using specific GTP-binding-protein antisera. , 1995, The Biochemical journal.
[75] H. Akil,et al. Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: An in situ hybridization study , 1994, The Journal of comparative neurology.
[76] M. Adler,et al. Effect of μ-, κ-, and δ-selective opioid agonists on thermoregulation in the rat , 1992, Pharmacology Biochemistry and Behavior.
[77] B. Moore,et al. Properties of the putative epsilon opioid receptor: identification in rat, guinea pig, cow, pig and chicken brain. , 1993, The Journal of pharmacology and experimental therapeutics.
[78] A. Faden,et al. Selective cardiorespiratory effects mediated by mu opioid receptors in the nucleus ambiguus , 1984, Neuropharmacology.
[79] P. Schiller,et al. Synthesis and binding characteristics of the highly specific, tritiated delta opioid antagonist [3H]TIPP. , 1993, Life sciences.
[80] W. E. Wilson,et al. Dermorphin gene sequence peptide with high affinity and selectivity for delta-opioid receptors. , 1989, The Journal of biological chemistry.
[81] J. Bidlack,et al. The kappa opioid receptor expressed on the mouse R1.1 thymoma cell line is coupled to adenylyl cyclase through a pertussis toxin-sensitive guanine nucleotide-binding regulatory protein. , 1993, The Journal of pharmacology and experimental therapeutics.
[82] L. Terenius. Stereospecific interaction between narcotic analgesics and a synaptic plasm a membrane fraction of rat cerebral cortex. , 2009, Acta pharmacologica et toxicologica.
[83] M. Millan. Kappa-opioid receptor-mediated antinociception in the rat. I. Comparative actions of mu- and kappa-opioids against noxious thermal, pressure and electrical stimuli. , 1989, The Journal of pharmacology and experimental therapeutics.
[84] S. Snyder,et al. Characterization of an endogenous morphine-like factor(enkephalin) in mammalian brain. , 1976, Molecular pharmacology.
[85] A. Goldstein,et al. Stereospecific and nonspecific interactions of the morphine congener levorphanol in subcellular fractions of mouse brain. , 1971, Proceedings of the National Academy of Sciences of the United States of America.
[86] B. Roques,et al. Deltakephalin, Tyr-D-Thr-Gly-Phe-Leu-Thr: a new highly potent and fully specific agonist for opiate delta-receptors. , 1983, Biochemical and biophysical research communications.
[87] H. Loh,et al. Properties of a kappa-opioid receptor expressed in CHO cells: interaction with multiple G-proteins is not specific for any individual G alpha subunit and is similar to that of other opioid receptors. , 1995, Brain research. Molecular brain research.
[88] Stanley N Cohen,et al. Nucleotide sequence of cloned cDNA for bovine corticotropin-β-lipotropin precursor , 1979, Nature.
[89] B. Gaehwiler,et al. Opiate antagonistic properties of an octapeptide somatostatin analog. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[90] D. Rees,et al. CI‐977, a novel and selective agonist for the κ‐opioid receptor , 1990, British journal of pharmacology.
[91] H. Rhim,et al. Opioid receptors modulate diverse types of calcium channels in the nucleus tractus solitarius of the rat , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[92] V. Hruby,et al. Conformationally restricted analogs of somatostatin with high mu-opiate receptor specificity. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[93] J. Thompson,et al. The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog. , 1976, The Journal of pharmacology and experimental therapeutics.
[94] W. Jin,et al. Opioids mobilize calcium from inositol 1,4,5-trisphosphate-sensitive stores in NG108-15 cells , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[95] M Price,et al. Receptor binding of [3H]naloxone benzoylhydrazone: a reversible kappa and slowly dissociable mu opiate. , 1989, Molecular pharmacology.
[96] R. North,et al. Opiate-receptor interactions on single locus coeruleus neurones. , 1984, Molecular pharmacology.
[97] P. Portoghese,et al. 7'-Substituted amino acid conjugates of naltrindole. Hydrophilic groups as determinants of selective antagonism of delta 1 opioid receptor-mediated antinociception in mice. , 1995, Journal of medicinal chemistry.
[98] T. Miyata,et al. cDNA cloning and regional distribution of a novel member of the opioid receptor family , 1994, FEBS letters.
[99] P. Portoghese,et al. A highly selective δ1-opioid receptor antagonist : 7-benzylidenenaltrexone , 1992 .
[100] P. Portoghese,et al. Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: evidence for delta opioid receptor subtypes. , 1991, The Journal of pharmacology and experimental therapeutics.
[101] L. Terenius,et al. ASSESSMENT IN THE GUINEA‐PIG ILEUM AND MOUSE VAS DEFERENS OF BENZOMORPHANS WHICH HAVE STRONG ANTINOCICEPTIVE ACTIVITY BUT DO NOT SUBSTITUTE FOR MORPHINE IN THE DEPENDENT MONKEY , 1975, British journal of pharmacology.
[102] A. Randich,et al. The use of specific opioid agonists and antagonists to delineate the vagally mediated antinociceptive and cardiovascular effects of intravenous morphine , 1993, Brain Research.
[103] R. Taussig,et al. Inhibition of the omega-conotoxin-sensitive calcium current by distinct G proteins. , 1992, Neuron.
[104] J. Leander. A kappa opioid effect: increased urination in the rat. , 1983, The Journal of pharmacology and experimental therapeutics.
[105] G. Uhl,et al. Expressed mu opiate receptor couples to adenylate cyclase and phosphatidyl inositol turnover. , 1994, Neuroreport.
[106] C. Chen,et al. Differential binding domains of peptide and non-peptide ligands in the cloned rat kappa opioid receptor. , 1994, The Journal of biological chemistry.
[107] T. Nakazawa,et al. Spinal kappa receptor-mediated analgesia of E-2078, a systemically active dynorphin analog, in mice. , 1991, The Journal of pharmacology and experimental therapeutics.
[108] W. Bowen,et al. Evidence for a single functional opioid delta receptor subtype in the mouse isolated vas deferens. , 1993, The Journal of pharmacology and experimental therapeutics.
[109] L. S. Bye,et al. Characterization of the cloned human mu opioid receptor. , 1995, The Journal of pharmacology and experimental therapeutics.
[110] P. Portoghese,et al. A single residue, aspartic acid 95, in the delta opioid receptor specifies selective high affinity agonist binding. , 1993, The Journal of biological chemistry.
[111] A. Goldstein,et al. Site-directed alkylation of multiple opioid receptors. I. Binding selectivity. , 1984, Molecular pharmacology.
[112] G. Bell,et al. Distribution of κ Opioid Receptor mRNA in Adult Mouse Brain: An in Situ Hybridization Histochemistry Study , 1994, Molecular and Cellular Neuroscience.
[113] J. Reubi,et al. Somatostatin Receptors , 1997, Trends in Endocrinology & Metabolism.
[114] Á. Pazos,et al. A comparative study in rats of the respiratory depression and analgesia induced by μ- and δ-opioid agonists , 1984 .
[115] M. Olianas,et al. Naturally occurring opioid receptor agonists stimulate adenylate cyclase activity in rat olfactory bulb. , 1991, Molecular pharmacology.
[116] R. Edwards,et al. Cloning of a delta opioid receptor by functional expression. , 1992, Science.
[117] Á. Márki,et al. CHARACTERIZATION OF KAPPA OPIOID RECEPTORS WITH TRITIATED norBNI , 1995 .
[118] C. N. Honda,et al. Immunohistochemical localization of delta‐ and mu‐opioid receptors in primate spinal cord , 1995, Neuroreport.
[119] D. Regoli,et al. RAT VAS DEFERENS: A SPECIFIC BIOASSAY FOR ENDOGENOUS OPIOID PEPTIDES , 1978, British journal of pharmacology.
[120] S. Harrison,et al. GR94839, a κ‐opioid agonist with limited access to the central nervous system, has antinociceptive activity , 1992, British journal of pharmacology.
[121] T. Katada,et al. A subtype of opioid κ‐receptor is coupled to inhibition of Gil‐mediated phospholipase C activity in the guinea pig cerebellum , 1995, FEBS letters.
[122] V. Hruby,et al. Design and synthesis of conformationally constrained somatostatin analogues with high potency and specificity for μ opioid receptors , 1986 .
[123] F. Cardinaux,et al. A SYNTHETIC ENKEPHALIN ANALOG WITH PROLONGED PARENTERAL AND ORAL ANALGESIC ACTIVITY , 1977 .
[124] Stanley J. Watson,et al. Cloning and pharmacological characterization of a rat μ opioid receptor , 1993, Neuron.
[125] M. Wick,et al. Isolation of a novel cDNA encoding a putative membrane receptor with high homology to the cloned mu, delta, and kappa opioid receptors. , 1994, Brain research. Molecular brain research.
[126] M. Spedding,et al. X. International Union of Pharmacology recommendations for nomenclature of new receptor subtypes. , 1996, Pharmacological reviews.
[127] G. Uhl,et al. Human mu opiate receptor. cDNA and genomic clones, pharmacologic characterization and chromosomal assignment. , 1994, FEBS letters.
[128] M. E. Lewis,et al. Anatomy of CNS opioid receptors , 1988, Trends in Neurosciences.
[129] A H BECKETT,et al. SYNTHETIC ANALGESICS: STEREOCHEMICAL CONSIDERATIONS , 1954, The Journal of pharmacy and pharmacology.
[130] Y. Wong,et al. Regulation of Multiple Effectors by the Cloned δ‐Opioid Receptor: Stimulation of Phospholipase C and Type II Adenylyl Cyclase , 1995, Journal of neurochemistry.
[131] G. Haddad,et al. Opposite effects of the δ- and μ-opioid receptor agonists on ventilation in conscious adult dogs , 1984, Brain Research.
[132] W. Sadee,et al. Characterization of a Labile Naloxone Binding Site (λ Site) in Rat Brain , 1985 .
[133] P. Portoghese,et al. TENA, a selective kappa opioid receptor antagonist. , 1985, Life sciences.
[134] M. Marcoli,et al. The opioid receptors in the hamster vas deferens are of the δ-type , 1985, Neuropharmacology.
[135] D. Grandy,et al. Orphanin FQ: A Neuropeptide That Activates an Opioidlike G Protein-Coupled Receptor , 1995, Science.
[136] Stanley J. Watson,et al. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications , 1995, Trends in Neurosciences.
[137] C. Li,et al. Isolation and structure of an untriakontapeptide with opiate activity from camel pituitary glands. , 1976, Proceedings of the National Academy of Sciences of the United States of America.
[138] V. Hruby,et al. Design and synthesis of somatostatin analogues with topographical properties that lead to highly potent and specific mu opioid receptor antagonists with greatly reduced binding at somatostatin receptors. , 1988, Journal of medicinal chemistry.
[139] W. Kromer. The current status of opioid research on gastrointestinal motility. , 1989, Life sciences.
[140] G. Pasternak,et al. Different mu receptor subtypes mediate spinal and supraspinal analgesia in mice. , 1989, European journal of pharmacology.
[141] S. Nakanishi,et al. Cloning and sequence analysis of cDNA for bovine adrenal preproenkephalin , 1982, Nature.
[142] C. Schmauss. Spinal κ-opioid receptor-mediated antinociception is stimulus-specific , 1987 .
[143] B. O'dowd,et al. Cloning, Characterization, and Distribution of a μ‐Opioid Receptor in Rat Brain , 1994 .
[144] R. Espinosa,et al. Localization of the kappa opioid receptor gene to human chromosome band 8q11.2. , 1994, Genomics.
[145] J. Champagnat,et al. Different effects of and d opiate agonists on respiration , 1984 .
[146] Shengwen Zhang,et al. Identification of Dynorphins as Endogenous Ligands for an Opioid Receptor-like Orphan Receptor (*) , 1995, The Journal of Biological Chemistry.
[147] V. Hruby,et al. Opioid receptor selectivity of beta-endorphin in vitro and in vivo: mu, delta and epsilon receptors. , 1988, The Journal of pharmacology and experimental therapeutics.
[148] T. Burks,et al. Supraspinal and spinal potency of selective opioid agonists in the mouse writhing test. , 1987, The Journal of pharmacology and experimental therapeutics.
[149] P. Portoghese,et al. A remarkable change of opioid receptor selectivity on the attachment of a peptidomimetic kappa address element to the delta antagonist, natrindole: 5'-[N2-alkylamidino)methyl]naltrindole derivatives as a novel class of kappa opioid receptor antagonists. , 1993, Journal of medicinal chemistry.
[150] J. Mathiasen,et al. [D-Pen2,L-Pen5]enkephalin induced analgesia in the jimpy mouse: in vivo evidence for delta-receptor mediated analgesia. , 1987, European journal of pharmacology.
[151] T. Reisine,et al. Agonists and antagonists bind to different domains of the cloned kappa opioid receptor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[152] R. Spanagel,et al. Evidence that nor-binaltorphimine can function as an antagonist at multiple opioid receptor subtypes. , 1994, European journal of pharmacology.
[153] R. Macdonald,et al. Mu- and kappa-opioid receptors selectively reduce the same transient components of high-threshold calcium current in rat dorsal root ganglion sensory neurons , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[154] B. Ozenberger,et al. cDNA Cloning of an orphan opiate receptor gene family member and its splice variant , 1994, FEBS letters.
[155] D. Manallack,et al. Psychotomimetic σ-opiates and PCP , 1986 .
[156] J. Kleinman,et al. Interaction of opioid peptides and other drugs with multiple kappa receptors in rat and human brain. Evidence for species differences , 1992, Peptides.
[157] J. Fishman,et al. Etonitazene: an opioid selective for the mu receptor types. , 1993, Life sciences.
[158] B. Morgan,et al. Analogues of beta-LPH61-64 possessing selective agonist activity at mu-opiate receptors. , 1981, European journal of pharmacology.
[159] G Vassart,et al. ORL1, a novel member of the opioid receptor family , 1994, FEBS letters.
[160] M. E. Meyer,et al. Behavioral effects of opioid peptide agonists DAMGO, DPDPE, and DAKLI on locomotor activities , 1993, Pharmacology Biochemistry and Behavior.
[161] M. Olianas,et al. Activation of Opioid and Muscarinic Receptors Stimulates Basal Adenylyl Cyclase but Inhibits Ca2+/Calmodulin‐ and Forskolin‐Stimulated Enzyme Activities in Rat Olfactory Bulb , 1994, Journal of neurochemistry.
[162] D. Hammond,et al. Antinociception after intracerebroventricular administration of naltrindole in the mouse. , 1992, European journal of pharmacology.
[163] T. Cicero,et al. Autoradiography of [3H]U-69593 binding sites in rat brain: evidence for κ opioid receptor subtypes , 1988 .
[164] G. Bell,et al. Cloning and functional comparison of kappa and delta opioid receptors from mouse brain. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[165] H. Kosterlitz,et al. COMPARISON OF THE BINDING CHARACTERISTICS OF TRITIATED OPIATES AND OPIOID PEPTIDES , 1980, British journal of pharmacology.
[166] T. Yaksh,et al. In vivo studies on spinal opiate receptor systems mediating antinociception. II. Pharmacological profiles suggesting a differential association of mu, delta and kappa receptors with visceral chemical and cutaneous thermal stimuli in the rat. , 1984, The Journal of pharmacology and experimental therapeutics.
[167] D. Scopes,et al. A series of novel, highly potent and selective agonists for the κ‐opioid receptor , 1990 .
[168] B. Giros,et al. Chromosomal localization of opioid peptide and receptor genes in the mouse. , 1995, Life sciences.
[169] C. Fowler,et al. μ-, δ-, κ-Opioid receptors and their subtypes. A critical review with emphasis on radioligand binding experiments , 1994, Neurochemistry International.
[170] H. Loh,et al. Genomic structure and analysis of promoter sequence of a mouse la opioid receptor gene , 2022 .
[171] D. Barra,et al. Deltorphin, a novel amphibian skin peptide with high selectivity and affinity for delta opioid receptors. , 1989, European journal of pharmacology.
[172] P. Portoghese. A new concept on the mode of interaction of narcotic analgesics with receptors. , 1965, Journal of medicinal chemistry.
[173] H. Loh,et al. Interaction of delta-opioid receptors with multiple G proteins: a non-relationship between agonist potency to inhibit adenylyl cyclase and to activate G proteins. , 1994, Molecular pharmacology.
[174] R. Raffa,et al. Examination of the involvement of supraspinal and spinal mu and delta opioid receptors in analgesia using the mu receptor deficient CXBK mouse. , 1988, The Journal of pharmacology and experimental therapeutics.
[175] V. Hruby,et al. Quantitative autoradiography of [3H]CTOP binding to mu opioid receptors in rat brain. , 1988, Life sciences.
[176] M. Chesselet,et al. Expression of Mu opioid receptor mRNA in rat brain: An in situ hybridization study at the single cell level , 1994, The Journal of comparative neurology.
[177] C. Chavkin,et al. Opioids activate both an inward rectifier and a novel voltage-gated potassium conductance in the hippocampal formation , 1991, Neuron.
[178] B. Roques,et al. [3H]Ohmefentanyl preferentially binds to μ-opioid receptors but also labels σ-sites in rat brain sections , 1991 .
[179] K. Mori,et al. cDNA cloning and pharmacological characterization of an opioid receptor with high affinities for κ‐subtype‐selective ligands , 1993, FEBS letters.
[180] K. Shen,et al. Cholera toxin-A subunit blocks opioid excitatory effects of sensory neuron action potentials indicating mediation by Gs-linked opioid receptors , 1990, Brain Research.
[181] A Goldstein,et al. Cloning and pharmacological characterization of a rat kappa opioid receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[182] B. Roques,et al. Comparative binding properties of linear and cyclic δ‐selective enkephalin analogues: [3H]‐[D‐Thr2, Leu5] enkephalyl‐Thr6 and [3H]‐[D‐Pen2, D‐Pen5] enkephalin , 1985, FEBS letters.
[183] V. Erspamer,et al. Dermorphin-related peptides from the skin of Phyllomedusa bicolor and their amidated analogs activate two mu opioid receptor subtypes that modulate antinociception and catalepsy in the rat. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[184] M Satoh,et al. Molecular pharmacology of the opioid receptors. , 1995, Pharmacology & therapeutics.
[185] John Hughes,et al. Endogenous opioid peptides: multiple agonists and receptors , 1977, Nature.
[186] C. Stein,et al. Peripheral Mechanisms of Opioid Analgesia , 1993, Anesthesia and analgesia.